Yang Meng
4PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|May 16, 2020
The cost effectiveness of pembrolizumab versus chemotherapy or atezolizumab as second-line therapy for advanced urothelial carcinoma in the United States.Rachael Louise Slater, Yizhen Lai, Yichen Zhong
|Nov 14, 2018
A review and validation of overall survival extrapolation in health technology assessments of cancer immunotherapy by the National Institute for Health and Care Excellence: how did the initial best estimate compare to trial data subsequently made available?Ash Bullement, Yang Meng, Miranda Cooper
|Mar 11, 2018
The cost-effectiveness of nivolumab monotherapy for the treatment of advanced melanoma patients in England.Yang Meng, Nadine Hertel, John Ellis
|Jul 01, 2017
Patient-reported health state utilities in metastatic gastroenteropancreatic neuroendocrine tumours - an analysis based on the CLARINET study.Yang Meng, Grant McCarthy, Anthony Berthon
Pageof 1
